Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$68.04 USD
-0.08 (-0.12%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $68.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for Exact Sciences Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,500 | 2,084 | 1,767 | 1,491 | 876 |
Cost Of Goods | 654 | 574 | 459 | 354 | 217 |
Gross Profit | 1,846 | 1,510 | 1,308 | 1,137 | 660 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,061 | 2,103 | 2,164 | 1,905 | 893 |
Income After Depreciation & Amortization | -215 | -594 | -856 | -768 | -234 |
Non-Operating Income | 33 | -19 | 32 | 7 | 27 |
Interest Expense | 19 | 20 | 19 | 96 | 62 |
Pretax Income | -202 | -633 | -843 | -857 | -269 |
Income Taxes | 2 | -9 | -247 | -9 | -185 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -204 | -624 | -596 | -849 | -84 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -204 | -624 | -596 | -849 | -84 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -371 | -644 | -321 | -149 |
Depreciation & Amortization (Cash Flow) | 207 | 223 | 212 | 447 | 85 |
Income After Depreciation & Amortization | -215 | -594 | -856 | -768 | -234 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 180.14 | 176.35 | 171.35 | 151.14 | 131.26 |
Diluted EPS Before Non-Recurring Items | -1.13 | -3.54 | -3.48 | -1.38 | -1.49 |
Diluted Net EPS (GAAP) | -1.13 | -3.54 | -3.48 | -5.61 | -0.64 |
Fiscal Year end for Exact Sciences Corporation falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 699.26 | 637.52 | 646.89 | 628.34 | 622.09 |
Cost Of Goods | 189.85 | 170.10 | 171.87 | 168.53 | 156.99 |
Gross Profit | 509.42 | 467.42 | 475.02 | 459.81 | 465.10 |
SG&A, R&D, and Dept/Amort Expenses | 535.67 | 574.12 | 542.86 | 452.97 | 542.04 |
Income After SG&A, R&D, and Dept/Amort Expenses | -26.25 | -106.70 | -67.84 | 6.84 | -76.94 |
Non-Operating Income | 11.80 | 6.21 | 25.33 | 2.07 | 4.83 |
Interest Expense | -0.11 | 7.94 | 7.87 | 7.87 | 7.82 |
Pretax Income | -14.35 | -108.42 | -50.38 | 1.04 | -79.92 |
Income Taxes | 1.46 | 1.81 | -0.61 | 0.25 | 1.11 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -15.81 | -110.23 | -49.77 | 0.79 | -81.03 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -15.81 | -110.23 | -49.77 | 0.79 | -81.03 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 184.31 | 182.35 | 181.11 | 184.08 | 180.20 |
Diluted EPS Before Non-Recurring Items | -0.09 | -0.50 | -0.27 | 0.00 | -0.45 |
Diluted Net EPS (GAAP) | -0.09 | -0.60 | -0.26 | 0.00 | -0.45 |